To construct plasmids that encoded for epitope-tagged fusion proteins, DNA fragments that contained the genes of interest were amplified by PCR with specific primers (
Table 2), and cloned into
pGEX-6P-1 (GE Healthcare) for N-terminal GST-tagged fusion proteins and
pFLAG-CTC (Sigma-Aldrich), p2HA-CTC [27] (
link), and pBAD-
Myc-HisC (Invitrogen) for C-terminal FLAG, 2HA, and Myc-His
6-tagged fusion proteins, respectively.
To construct the complementing pSsaN plasmid that expressed SsaN-FLAG fusion proteins, the
ssaN-flag gene was amplified from the pFLAG-SsaN plasmid using the primers FLAG-SphI-FW and FLAG-BamHI-RV (
Table 2), and then ligated into a low-copy-number pMW119 vector (Nippon Gene).
A point mutation in the
ssaN gene was created with a QuikChange Site-directed mutagenesis kit (Stratagene) using the primers SsaN-R192G-FW and SsaN-R192G-RV (
Table 2) to replace arginine with glycine at position 192 in SsaN. This mutation was confirmed by DNA sequencing.
Yoshida Y., Miki T., Ono S., Haneda T., Ito M, & Okada N. (2014). Functional Characterization of the Type III Secretion ATPase SsaN Encoded by Salmonella Pathogenicity Island 2. PLoS ONE, 9(4), e94347.